Quick Takeaways
- This page summarizes Michael E. Sneed's Form 4 filing for Kenvue Inc. (KVUE).
- 2 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 25 Aug 2023, 18:23.
Michael E. Sneed - 23 Aug 2023 Form 4 Insider Report for Kenvue Inc. (KVUE)
- Role
- Director
- Signature
- /s/ Alla Berenshteyn, as attorney-in-fact
- Issuer symbol
- KVUE
- Transactions as of
- 23 Aug 2023
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 25 Aug 2023, 18:23:12 UTC
- Previous filing
- 08 May 2023
- Next filing
- 13 Nov 2023
- SEC
- View on sec.gov
Quoteable Key Fact
"Michael E. Sneed filed Form 4 for Kenvue Inc. (KVUE) on 25 Aug 2023."
What Changed
- Previous filing in this sequence was filed on 08 May 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
KVUE
transaction
Common Stock
Other
- Transaction value
- Shares
- +10,787
- Change %
- Price
- Shares after
- 10,787
- Date
- 23 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
KVUE
transaction
Derivative
Deferred Share Units
Award
- Transaction value
- $0
- Shares
- +7,620
- Change %
- Price
- $0.000000
- Shares after
- 7,620
- Date
- 23 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,620
- Exercise price
- Footnotes
- F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | On July 24, 2023, Johnson & Johnson commenced a registered exchange offer to holders of shares of Johnson & Johnson common stock to exchange Johnson & Johnson common stock for Kenvue Inc. ("Kenvue") common stock. The final exchange ratio was 8.0324 shares of Kenvue common stock per share of Johnson & Johnson common stock accepted in the exchange offer. |
| F2 | Grant of Deferred Share Units acquired under the Issuer's Deferred Fee Plan for Directors are to be settled in cash upon termination of the Reporting Person's directorship (with each Deferred Share Unit representing the fair market value of one share of Common Stock on the settlement date). |